ID   PDE1B_HUMAN             Reviewed;         536 AA.
AC   Q01064; Q92825; Q96KP3;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 2.
DT   10-MAY-2017, entry version 164.
DE   RecName: Full=Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B;
DE            Short=Cam-PDE 1B;
DE            EC=3.1.4.17;
DE   AltName: Full=63 kDa Cam-PDE;
GN   Name=PDE1B; Synonyms=PDE1B1, PDES1B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PDE1B1).
RX   PubMed=8855339; DOI=10.1073/pnas.93.20.11236;
RA   Jiang X., Li J., Paskind M., Epstein P.M.;
RT   "Inhibition of calmodulin-dependent phosphodiesterase induces
RT   apoptosis in human leukemic cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:11236-11241(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PDE1B1).
RC   TISSUE=Brain;
RX   PubMed=9419816; DOI=10.1016/S0898-6568(97)00046-6;
RA   Yu J., Frazier A.L.B., Wolda S.L., Florio V.A., Martins T.J.,
RA   Snyder P.B., Harris E.A.S., McCaw K.N., Farrell C.A., Steiner B.,
RA   Bentley J.K., Beavo J.A., Ferguson K., Gelinas R.;
RT   "Identification and characterisation of a human calmodulin-stimulated
RT   phosphodiesterase PDE1B1.";
RL   Cell. Signal. 9:519-529(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PDE1B2).
RC   TISSUE=Testis;
RX   PubMed=11747989; DOI=10.1016/S0898-6568(01)00207-8;
RA   Fidock M.D., Miller M., Lanfear J.;
RT   "Isolation and differential tissue distribution of two human cDNAs
RT   encoding PDE1 splice variants.";
RL   Cell. Signal. 14:53-60(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM PDE1B2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM PDE1B1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 222-337.
RX   PubMed=1326532;
RA   Repaske D.R., Swinnen J.V., Jin S.-L.C., van Wyk J.J., Conti M.;
RT   "A polymerase chain reaction strategy to identify and clone cyclic
RT   nucleotide phosphodiesterase cDNAs. Molecular cloning of the cDNA
RT   encoding the 63-kDa calmodulin-dependent phosphodiesterase.";
RL   J. Biol. Chem. 267:18683-18688(1992).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.77 ANGSTROMS) OF 146-506 IN COMPLEX WITH
RP   METAL IONS, COFACTOR, AND FUNCTION.
RX   PubMed=15260978; DOI=10.1016/j.molcel.2004.07.005;
RA   Zhang K.Y.J., Card G.L., Suzuki Y., Artis D.R., Fong D., Gillette S.,
RA   Hsieh D., Neiman J., West B.L., Zhang C., Milburn M.V., Kim S.-H.,
RA   Schlessinger J., Bollag G.;
RT   "A glutamine switch mechanism for nucleotide selectivity by
RT   phosphodiesterases.";
RL   Mol. Cell 15:279-286(2004).
CC   -!- FUNCTION: Cyclic nucleotide phosphodiesterase with a dual-
CC       specificity for the second messengers cAMP and cGMP, which are key
CC       regulators of many important physiological processes. Has a
CC       preference for cGMP as a substrate. {ECO:0000269|PubMed:15260978}.
CC   -!- CATALYTIC ACTIVITY: Nucleoside 3',5'-cyclic phosphate + H(2)O =
CC       nucleoside 5'-phosphate.
CC   -!- COFACTOR:
CC       Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;
CC         Evidence={ECO:0000269|PubMed:15260978};
CC       Note=Binds 2 divalent metal cations per subunit. Site 1 may
CC       preferentially bind zinc ions, while site 2 has a preference for
CC       magnesium and/or manganese ions. {ECO:0000269|PubMed:15260978};
CC   -!- ENZYME REGULATION: Type I PDE are activated by the binding of
CC       calmodulin in the presence of Ca(2+).
CC   -!- SUBUNIT: Homodimer. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q9NUX5:POT1; NbExp=2; IntAct=EBI-7413304, EBI-752420;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=PDE1B1;
CC         IsoId=Q01064-1; Sequence=Displayed;
CC       Name=PDE1B2;
CC         IsoId=Q01064-2; Sequence=VSP_038643, VSP_038644;
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterase
CC       family. PDE1 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U56976; AAC50769.1; -; mRNA.
DR   EMBL; U86078; AAC51872.1; -; mRNA.
DR   EMBL; AJ401609; CAC82207.1; -; mRNA.
DR   EMBL; AK302931; BAG64092.1; -; mRNA.
DR   EMBL; CH471054; EAW96790.1; -; Genomic_DNA.
DR   EMBL; BC032226; AAH32226.1; -; mRNA.
DR   EMBL; M94539; AAA58405.1; -; mRNA.
DR   CCDS; CCDS53800.1; -. [Q01064-2]
DR   CCDS; CCDS8882.1; -. [Q01064-1]
DR   PIR; JC6129; JC6129.
DR   RefSeq; NP_000915.1; NM_000924.3. [Q01064-1]
DR   RefSeq; NP_001159447.1; NM_001165975.2. [Q01064-2]
DR   RefSeq; NP_001275697.1; NM_001288768.1.
DR   RefSeq; NP_001275698.1; NM_001288769.1.
DR   RefSeq; NP_001302463.1; NM_001315534.1.
DR   RefSeq; NP_001302464.1; NM_001315535.1.
DR   UniGene; Hs.530871; -.
DR   PDB; 1LXR; Model; -; A=158-461.
DR   PDB; 1TAZ; X-ray; 1.77 A; A=146-506.
DR   PDB; 4NPV; X-ray; 2.40 A; A=142-507.
DR   PDB; 4NPW; X-ray; 1.90 A; A=142-507.
DR   PDB; 5B25; X-ray; 1.90 A; A/B/C/D=146-506.
DR   PDBsum; 1LXR; -.
DR   PDBsum; 1TAZ; -.
DR   PDBsum; 4NPV; -.
DR   PDBsum; 4NPW; -.
DR   PDBsum; 5B25; -.
DR   ProteinModelPortal; Q01064; -.
DR   SMR; Q01064; -.
DR   BioGrid; 111179; 3.
DR   IntAct; Q01064; 2.
DR   STRING; 9606.ENSP00000243052; -.
DR   BindingDB; Q01064; -.
DR   ChEMBL; CHEMBL4425; -.
DR   DrugBank; DB01244; Bepridil.
DR   DrugBank; DB00201; Caffeine.
DR   DrugBank; DB01023; Felodipine.
DR   DrugBank; DB00622; Nicardipine.
DR   GuidetoPHARMACOLOGY; 1295; -.
DR   iPTMnet; Q01064; -.
DR   PhosphoSitePlus; Q01064; -.
DR   BioMuta; PDE1B; -.
DR   DMDM; 3183514; -.
DR   MaxQB; Q01064; -.
DR   PaxDb; Q01064; -.
DR   PeptideAtlas; Q01064; -.
DR   PRIDE; Q01064; -.
DR   DNASU; 5153; -.
DR   Ensembl; ENST00000243052; ENSP00000243052; ENSG00000123360. [Q01064-1]
DR   Ensembl; ENST00000550620; ENSP00000448519; ENSG00000123360. [Q01064-2]
DR   GeneID; 5153; -.
DR   KEGG; hsa:5153; -.
DR   UCSC; uc001sgd.3; human. [Q01064-1]
DR   CTD; 5153; -.
DR   DisGeNET; 5153; -.
DR   GeneCards; PDE1B; -.
DR   HGNC; HGNC:8775; PDE1B.
DR   HPA; HPA018492; -.
DR   MIM; 171891; gene.
DR   neXtProt; NX_Q01064; -.
DR   OpenTargets; ENSG00000123360; -.
DR   PharmGKB; PA33123; -.
DR   eggNOG; KOG3688; Eukaryota.
DR   eggNOG; ENOG410XQDD; LUCA.
DR   GeneTree; ENSGT00760000118889; -.
DR   HOGENOM; HOG000231888; -.
DR   HOVERGEN; HBG056120; -.
DR   KO; K13755; -.
DR   OMA; LMQDDEM; -.
DR   OrthoDB; EOG091G04C4; -.
DR   PhylomeDB; Q01064; -.
DR   TreeFam; TF314638; -.
DR   BRENDA; 3.1.4.17; 2681.
DR   Reactome; R-HSA-111957; Cam-PDE 1 activation.
DR   Reactome; R-HSA-418457; cGMP effects.
DR   Reactome; R-HSA-418555; G alpha (s) signalling events.
DR   EvolutionaryTrace; Q01064; -.
DR   GeneWiki; PDE1B; -.
DR   GenomeRNAi; 5153; -.
DR   PRO; PR:Q01064; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000123360; -.
DR   CleanEx; HS_PDE1B; -.
DR   ExpressionAtlas; Q01064; baseline and differential.
DR   Genevisible; Q01064; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0004115; F:3',5'-cyclic-AMP phosphodiesterase activity; TAS:Reactome.
DR   GO; GO:0047555; F:3',5'-cyclic-GMP phosphodiesterase activity; TAS:Reactome.
DR   GO; GO:0048101; F:calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity; IEA:Ensembl.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0004117; F:calmodulin-dependent cyclic-nucleotide phosphodiesterase activity; TAS:ProtInc.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006915; P:apoptotic process; TAS:ProtInc.
DR   GO; GO:0006198; P:cAMP catabolic process; IDA:UniProtKB.
DR   GO; GO:0097011; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; IDA:UniProtKB.
DR   GO; GO:0036006; P:cellular response to macrophage colony-stimulating factor stimulus; IDA:UniProtKB.
DR   GO; GO:0046069; P:cGMP catabolic process; IDA:UniProtKB.
DR   GO; GO:0007626; P:locomotory behavior; IEA:Ensembl.
DR   GO; GO:0030224; P:monocyte differentiation; IEP:UniProtKB.
DR   GO; GO:0042053; P:regulation of dopamine metabolic process; IEA:Ensembl.
DR   GO; GO:0001505; P:regulation of neurotransmitter levels; IEA:Ensembl.
DR   GO; GO:0001975; P:response to amphetamine; IEA:Ensembl.
DR   GO; GO:0042428; P:serotonin metabolic process; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; IEA:Ensembl.
DR   GO; GO:0008542; P:visual learning; IEA:Ensembl.
DR   Gene3D; 1.10.1300.10; -; 1.
DR   InterPro; IPR003607; HD/PDEase_dom.
DR   InterPro; IPR023088; PDEase.
DR   InterPro; IPR002073; PDEase_catalytic_dom.
DR   InterPro; IPR023174; PDEase_CS.
DR   InterPro; IPR013706; PDEase_N.
DR   Pfam; PF00233; PDEase_I; 1.
DR   Pfam; PF08499; PDEase_I_N; 1.
DR   PRINTS; PR00387; PDIESTERASE1.
DR   SMART; SM00471; HDc; 1.
DR   PROSITE; PS00126; PDEASE_I; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calmodulin-binding; cAMP; cGMP;
KW   Complete proteome; Cytoplasm; Hydrolase; Metal-binding;
KW   Phosphoprotein; Reference proteome.
FT   CHAIN         1    536       Calcium/calmodulin-dependent 3',5'-cyclic
FT                                nucleotide phosphodiesterase 1B.
FT                                /FTId=PRO_0000198789.
FT   REGION       27     47       Calmodulin-binding. {ECO:0000255}.
FT   REGION      197    496       Catalytic. {ECO:0000250}.
FT   ACT_SITE    223    223       Proton donor.
FT                                {ECO:0000250|UniProtKB:O76083}.
FT   METAL       227    227       Divalent metal cation 1; via tele
FT                                nitrogen. {ECO:0000244|PDB:1TAZ,
FT                                ECO:0000244|PDB:4NPV,
FT                                ECO:0000244|PDB:4NPW,
FT                                ECO:0000269|PubMed:15260978}.
FT   METAL       263    263       Divalent metal cation 1; via tele
FT                                nitrogen. {ECO:0000244|PDB:1TAZ,
FT                                ECO:0000244|PDB:4NPV,
FT                                ECO:0000244|PDB:4NPW,
FT                                ECO:0000269|PubMed:15260978}.
FT   METAL       264    264       Divalent metal cation 1.
FT                                {ECO:0000244|PDB:1TAZ,
FT                                ECO:0000244|PDB:4NPV,
FT                                ECO:0000244|PDB:4NPW,
FT                                ECO:0000269|PubMed:15260978}.
FT   METAL       264    264       Divalent metal cation 2.
FT                                {ECO:0000244|PDB:1TAZ,
FT                                ECO:0000244|PDB:4NPV,
FT                                ECO:0000244|PDB:4NPW,
FT                                ECO:0000269|PubMed:15260978}.
FT   METAL       370    370       Divalent metal cation 1.
FT                                {ECO:0000244|PDB:1TAZ,
FT                                ECO:0000244|PDB:4NPV,
FT                                ECO:0000244|PDB:4NPW,
FT                                ECO:0000269|PubMed:15260978}.
FT   MOD_RES       7      7       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q01065}.
FT   MOD_RES      15     15       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q01065}.
FT   MOD_RES     466    466       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q01065}.
FT   MOD_RES     514    514       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q01065}.
FT   VAR_SEQ       1     18       MELSPRSPPEMLEESDCP -> MANPVPVQRSHLQGPILR
FT                                (in isoform PDE1B2).
FT                                {ECO:0000303|PubMed:11747989,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_038643.
FT   VAR_SEQ      19     38       Missing (in isoform PDE1B2).
FT                                {ECO:0000303|PubMed:11747989,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_038644.
FT   CONFLICT    225    226       QI -> SM (in Ref. 2; AAA58405).
FT                                {ECO:0000305}.
FT   CONFLICT    337    337       S -> A (in Ref. 2; AAA58405).
FT                                {ECO:0000305}.
FT   HELIX       152    158       {ECO:0000244|PDB:1TAZ}.
FT   TURN        159    162       {ECO:0000244|PDB:1TAZ}.
FT   HELIX       168    174       {ECO:0000244|PDB:1TAZ}.
FT   HELIX       179    190       {ECO:0000244|PDB:1TAZ}.
FT   HELIX       193    196       {ECO:0000244|PDB:1TAZ}.
FT   HELIX       201    215       {ECO:0000244|PDB:1TAZ}.
FT   TURN        216    218       {ECO:0000244|PDB:1TAZ}.
FT   STRAND      221    224       {ECO:0000244|PDB:1TAZ}.
FT   HELIX       225    242       {ECO:0000244|PDB:1TAZ}.
FT   HELIX       244    247       {ECO:0000244|PDB:1TAZ}.
FT   HELIX       250    262       {ECO:0000244|PDB:1TAZ}.
FT   TURN        263    266       {ECO:0000244|PDB:1TAZ}.
FT   HELIX       272    278       {ECO:0000244|PDB:1TAZ}.
FT   HELIX       281    286       {ECO:0000244|PDB:1TAZ}.
FT   HELIX       291    303       {ECO:0000244|PDB:1TAZ}.
FT   HELIX       307    309       {ECO:0000244|PDB:1TAZ}.
FT   TURN        311    314       {ECO:0000244|PDB:1TAZ}.
FT   HELIX       317    332       {ECO:0000244|PDB:1TAZ}.
FT   HELIX       336    338       {ECO:0000244|PDB:1TAZ}.
FT   HELIX       339    351       {ECO:0000244|PDB:1TAZ}.
FT   HELIX       358    370       {ECO:0000244|PDB:1TAZ}.
FT   HELIX       373    375       {ECO:0000244|PDB:1TAZ}.
FT   HELIX       378    402       {ECO:0000244|PDB:1TAZ}.
FT   HELIX       414    427       {ECO:0000244|PDB:1TAZ}.
FT   HELIX       429    444       {ECO:0000244|PDB:1TAZ}.
FT   TURN        446    448       {ECO:0000244|PDB:5B25}.
FT   HELIX       476    501       {ECO:0000244|PDB:1TAZ}.
SQ   SEQUENCE   536 AA;  61380 MW;  D15211AC32C756A4 CRC64;
     MELSPRSPPE MLEESDCPSP LELKSAPSKK MWIKLRSLLR YMVKQLENGE INIEELKKNL
     EYTASLLEAV YIDETRQILD TEDELQELRS DAVPSEVRDW LASTFTQQAR AKGRRAEEKP
     KFRSIVHAVQ AGIFVERMFR RTYTSVGPTY STAVLNCLKN LDLWCFDVFS LNQAADDHAL
     RTIVFELLTR HNLISRFKIP TVFLMSFLDA LETGYGKYKN PYHNQIHAAD VTQTVHCFLL
     RTGMVHCLSE IELLAIIFAA AIHDYEHTGT TNSFHIQTKS ECAIVYNDRS VLENHHISSV
     FRLMQDDEMN IFINLTKDEF VELRALVIEM VLATDMSCHF QQVKTMKTAL QQLERIDKPK
     ALSLLLHAAD ISHPTKQWLV HSRWTKALME EFFRQGDKEA ELGLPFSPLC DRTSTLVAQS
     QIGFIDFIVE PTFSVLTDVA EKSVQPLADE DSKSKNQPSF QWRQPSLDVE VGDPNPDVVS
     FRSTWVKRIQ ENKQKWKERA ASGITNQMSI DELSPCEEEA PPSPAEDEHN QNGNLD
//
